A detailed history of Northwest Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Wealth Management, LLC holds 1,698 shares of ABBV stock, worth $291,597. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,698
Previous 1,690 0.47%
Holding current value
$291,597
Previous $289,000 15.92%
% of portfolio
0.08%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $1,310 - $1,594
8 Added 0.47%
1,698 $335,000
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $3,405 - $3,976
22 Added 1.32%
1,690 $289,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $36,598 - $41,700
-229 Reduced 12.07%
1,668 $303,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $7,430 - $8,368
-54 Reduced 2.77%
1,897 $293,000
Q3 2023

Nov 01, 2023

SELL
$133.59 - $154.65 $45,287 - $52,426
-339 Reduced 14.8%
1,951 $290,000
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $4,372 - $5,441
33 Added 1.46%
2,290 $308,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $723 - $832
-5 Reduced 0.22%
2,257 $359,000
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $21,852 - $26,207
158 Added 7.51%
2,262 $365,000
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $41,873 - $48,026
-312 Reduced 12.91%
2,104 $282,000
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $83,397 - $106,025
606 Added 33.48%
2,416 $370,000
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $238,883 - $296,387
1,810 New
1,810 $293,000
Q3 2021

Oct 20, 2021

SELL
$106.4 - $120.78 $336,968 - $382,510
-3,167 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $333,200 - $371,204
3,167 New
3,167 $357,000
Q2 2019

Jul 23, 2019

SELL
$65.7 - $83.98 $53,414 - $68,275
-813 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$77.14 - $90.79 $7,714 - $9,079
100 Added 14.03%
813 $65,000
Q1 2018

Apr 13, 2018

BUY
$92.01 - $123.21 $65,603 - $87,848
713 New
713 $68,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwest Wealth Management, LLC Portfolio

Follow Northwest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Wealth Management, LLC with notifications on news.